- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genomma Lab Internacional SAB De CV (LABB)
Genomma Lab Internacional SAB De CV stock price live, this page displays BMV LABB stock exchange data. View the LABB premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genomma Lab Internacional SAB De CV real time stock price chart below.
What Is the Genomma Lab Internacional SAB De CV Stock Price Today?
The Genomma Lab Internacional SAB De CV stock price today is 15,660.
What Is the Stock Symbol for Genomma Lab Internacional SAB De CV?
The stock symbol for Genomma Lab Internacional SAB De CV is "LABB."
What Stock Exchange Does Genomma Lab Internacional SAB De CV Trade On?
Genomma Lab Internacional SAB De CV is listed and trades on the Mexico stock exchange.
Is Genomma Lab Internacional SAB De CV a Good Stock to Buy?
Determining whether Genomma Lab Internacional SAB De CV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LABB quote. (ISIN: MX01LA010006)
What Is the Genomma Lab Internacional SAB De CV Stock Price Today?
The Genomma Lab Internacional SAB De CV stock price today is 15,660.
What Is the Stock Symbol for Genomma Lab Internacional SAB De CV?
The stock symbol for Genomma Lab Internacional SAB De CV is "LABB."
What Stock Exchange Does Genomma Lab Internacional SAB De CV Trade On?
Genomma Lab Internacional SAB De CV is listed and trades on the Mexico stock exchange.
Is Genomma Lab Internacional SAB De CV a Good Stock to Buy?
Determining whether Genomma Lab Internacional SAB De CV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LABB quote. (ISIN: MX01LA010006)
15.660
+0.330(+2.15%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.200
15.700
52 wk Range
12.220
19.480
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
15.20015.700
52 wk Range
12.22019.480
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LABB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
21.333
Upside
+36.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Genomma Lab B receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Genomma Lab B receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 21.333
(+36.23% Upside)
Genomma Lab Internacional SAB De CV Earnings Call Summary for Q3/2026
- Genomma Lab exceeded Q3 estimates with EPS of $0.51 vs. $0.46 forecast and revenue of $4.5B vs. $4.43B, driven by Mexico's third consecutive quarter of improvement.
- EBITDA margin fell 271 bps to 21% as management prioritized growth investments over near-term profitability; expects recovery to 23-24% range over time.
- U.S. operations remained weak with sales down 30% and sell-out declining 8.8%, though management cited Suerox gains and e-commerce as stabilization signals.
- Company targets cash conversion cycle improvement to 140 days by Q4-end from 165 days, with free cash flow surging 52% YoY to MXN 470M.
- Management projects Mexico margins to recover from current 20% level; plans investor day Dec. 3 to unveil new operating model and AI platform initiatives.
Last Updated: 2026/10/22, 20:14
Read Full TranscriptEarnings
Latest Release
Oct 21, 2026
EPS / Forecast
0,51 / 0,46
Revenue / Forecast
4,5B / 4,43B
Compare LABB to Peers and Sector
Metrics to compare | LABB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLABBPeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.7x | 12.6x | −0.3x | |
PEG Ratio | 0.60 | 0.00 | 0.00 | |
Price/Book | 1.2x | 1.5x | 2.6x | |
Price / LTM Sales | 0.9x | 2.0x | 2.8x | |
Upside (Analyst Target) | 39.2% | 25.5% | 64.7% | |
Fair Value Upside | Unlock | 7.2% | 9.6% | Unlock |
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Genomma Lab Internacional (LABB) Stock Price Today?
The Genomma Lab Internacional stock price today is 15,660 MXN.
What Stock Exchange Does Genomma Lab Internacional Trade On?
Genomma Lab Internacional is listed and trades on the Mexico Stock Exchange.
What Is the Stock Symbol for Genomma Lab Internacional?
The stock symbol for Genomma Lab Internacional is "LABB."
Does Genomma Lab Internacional Pay Dividends? What’s The Current Dividend Yield?
The Genomma Lab Internacional dividend yield is 5,2%%.
What Is the Genomma Lab Internacional Market Cap?
As of today, Genomma Lab Internacional market cap is 15,240B MXN.
What Is Genomma Lab Internacional's Earnings Per Share (TTM)?
The Genomma Lab Internacional EPS (TTM) is 1,28.
When Is the Next Genomma Lab Internacional Earnings Date?
Genomma Lab Internacional will release its next earnings report on Feb 24, 2027.
From a Technical Analysis Perspective, Is LABB a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Genomma Lab Internacional Stock Split?
Genomma Lab Internacional has split 1 times.
How Many Employees Does Genomma Lab Internacional Have?
Genomma Lab Internacional has 1658 employees.
What is the current trading status of Genomma Lab Internacional (LABB)?
As of Oct 27, 2026, Genomma Lab Internacional (LABB) is trading at a price of 15,660 MXN, with a previous close of 15,330 MXN. The stock has fluctuated within a day range of 15,200 MXN to 15,700 MXN, while its 52-week range spans from 12,220 MXN to 19,480 MXN.
What Is Genomma Lab Internacional (LABB) Price Target According to Analysts?
The average 12-month price target for Genomma Lab Internacional is 21,333 MXN, with a high estimate of 29 MXN and a low estimate of 16 MXN. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +36,23% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.